SCHEMBL7702848

SCHEMBL7702848

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)c1cccc(F)c1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 7/20 0.54
KDR P35968 4/20 0.53
CDK1 P06493 2/20 0.50
CDK2 P24941 1/20 0.50
ROCK2 O75116 2/20 0.42
NAMPT P43490 1/20 0.42
DCLK1 O15075 1/20 0.42
DYRK3 O43781 1/20 0.42
PRKD3 O94806 1/20 0.42
MAP4K4 O95819 1/20 0.42
ABL1 P00519 1/20 0.42
EGFR P00533 1/20 0.42
NTRK1 P04629 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
CSF1R P07333 1/20 0.42
LYN P07948 1/20 0.42
SRC P12931 1/20 0.42
MARK3 P27448 1/20 0.42
AXL P30530 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697888 0.93 CHEK1 (0.57) CHEK1KDRCDK1CDK2MEN1
SCHEMBL7094478 0.89 CHEK1 (0.49) CHEK1KDRCDK1ROCK2DCLK1
SCHEMBL7702867 0.85 CHEK1 (0.53) CHEK1KDRCDK1CDK2TDP1
SCHEMBL7700585 0.85 CHEK1 (0.53) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL7696243 0.83 CHEK1 (0.57) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL7093397 0.82 CHEK1 (0.54) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL7094928 0.82 KDR (0.64) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL7091231 0.82 CHEK1 (0.56) CHEK1KDRCDK1CDK2ROCK2
Water SCHEMBL7089950 0.81 KDR (0.63) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL6998221 0.81 NPC1 (0.52) CHEK1KDRMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed